Medgraph, Inc. v. Medtronic, Inc., No. 15-2019 (Fed. Cir. Dec. 13, 2016)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Medgraph, Inc. (“Medgraph”) appeals from the dec i- sion of the United States District Court for the Western District of New York, dismissing with prejudice Me d- graph’s claims of infringement of U.S. Patent 5,974,124 (“the ’124 patent”) and U.S. Patent 6,122,351 (“the ’351 patent”) (collectively , the “ asserted patents”) against Medtronic, Inc. (“Medtronic”). See Medgraph, Inc. v. Medtronic, Inc., 111 F. Supp. 3d 346, 34 8 (W.D.N.Y. 2015) (“Decision”). For the reasons that follow, we affirm.